Genetically personalised organ-specific metabolic models in health and disease
View ORCID ProfileCarles Foguet, Yu Xu, View ORCID ProfileScott C. Ritchie, View ORCID ProfileSamuel A. Lambert, Elodie Persyn, View ORCID ProfileArtika P. Nath, View ORCID ProfileEmma E. Davenport, David J. Roberts, View ORCID ProfileDirk S. Paul, View ORCID ProfileEmanuele Di Angelantonio, John Danesh, View ORCID ProfileAdam S. Butterworth, View ORCID ProfileChristopher Yau, View ORCID ProfileMichael Inouye
doi: https://doi.org/10.1101/2022.03.25.22272958
Carles Foguet
1Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
2Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom
Yu Xu
1Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
3British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Scott C. Ritchie
1Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
3British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
4British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom
5Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
Samuel A. Lambert
1Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
3British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Elodie Persyn
1Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
3British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Artika P. Nath
1Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
5Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
Emma E. Davenport
6Wellcome Sanger Institute, Hinxton, United Kingdom
David J. Roberts
7BRC Haematology Theme, Radcliffe Department of Medicine, and NHSBT-Oxford, John Radcliffe Hospital, Oxford, UK
Dirk S. Paul
3British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
4British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom
Emanuele Di Angelantonio
2Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom
3British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
4British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom
8National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK
John Danesh
2Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom
3British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
4British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom
Adam S. Butterworth
2Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom
3British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
4British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom
Christopher Yau
9Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford, OX3 9DU, UK
10Division of Informatics, Imaging and Data Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK
11Health Data Research UK, Gibbs Building, 215 Euston Road, London, NW1 2BE, UK
12The Alan Turing Institute, London, United Kingdom
Michael Inouye
1Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
2Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom
3British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
4British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom
5Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
12The Alan Turing Institute, London, United Kingdom

Article usage
Posted March 31, 2022.
Genetically personalised organ-specific metabolic models in health and disease
Carles Foguet, Yu Xu, Scott C. Ritchie, Samuel A. Lambert, Elodie Persyn, Artika P. Nath, Emma E. Davenport, David J. Roberts, Dirk S. Paul, Emanuele Di Angelantonio, John Danesh, Adam S. Butterworth, Christopher Yau, Michael Inouye
medRxiv 2022.03.25.22272958; doi: https://doi.org/10.1101/2022.03.25.22272958
Genetically personalised organ-specific metabolic models in health and disease
Carles Foguet, Yu Xu, Scott C. Ritchie, Samuel A. Lambert, Elodie Persyn, Artika P. Nath, Emma E. Davenport, David J. Roberts, Dirk S. Paul, Emanuele Di Angelantonio, John Danesh, Adam S. Butterworth, Christopher Yau, Michael Inouye
medRxiv 2022.03.25.22272958; doi: https://doi.org/10.1101/2022.03.25.22272958
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)